USPTO serial 78246735
EFFIPURE
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- ANKRAH, NAAKWAMA S
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with EFFIPURE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Douglas R. Wolf
DOUGLAS R WOLF WOLF, GREENFIELD & SACKS PC600 ATLANTIC AVEBOSTON, MA 02210UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Reagents for clinical medical use; Reagents for clinical medical use in binding assays, namely assays to detect nucleic acid sequences; Reagents for clinical medical use in binding assays, namely assays to purify nucleic acid sequences; Reagents for clinical medical use in binding assays, namely assays to separate nucleic acid sequences; Reagents for clinical medical use in hybridization assays, namely assays to detect nucleic acid sequences; Reagents for clinical medical use in hybridization assays, namely assays to purify nucleic acid sequences; Reagents for clinical medical use in hybridization assays, namely assays to separate nucleic acid sequences; Reagents for clinical medical use in diagnostic electrophoresis assays; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect analytes; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to purify analytes; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to separate analytes; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect nucleic acid sequences; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to purify nucleic acid sequences; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to separate nucleic acid sequences; Reagents for clinical medical use in electrophoresis assays, namely assays to detect contamination in food products; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect contamination in blood products; Reagents for clinical medical use in electrophoresis assays, namely assays to detect biological contamination; Reagents for clinical medical use in electrophoresis assays, namely assays to detect biological contamination in food products; Reagents for clinical medical use in electrophoresis assays, namely assays to detect contamination in blood products; Reagents for clinical medical use in electrophoresis assays, namely assays to detect pathogenic contamination; Reagents for clinical medical use in electrophoresis assays, namely assays to detect food contamination; Reagents for clinical medical use in electrophoresis assays, namely assays to detect blood contamination; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect bacterial contamination in blood products; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect viral contamination in blood products; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect contamination in platelet products; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect bacterial contamination in platelet products; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to identify bacterial pathogens in platelet products; Reagent kits comprised of reagents for clinical medical use; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect analytes; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to purify analytes; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to separate analytes; Reagent kits comprised of reagents for clinical medical use, namely assays to detect nucleic acid sequences; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to purify nucleic acid sequences; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to separate nucleic acid sequences; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect contamination in blood products; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect bacterial contamination in blood products; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect viral contamination in blood products; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect contamination in platelet products; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect bacterial contamination in platelet products; and Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to identify bacterial pathogens | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 13, 2005 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 13, 2005 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 17, 2005 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 17, 2005 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 5, 2005 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Mar 30, 2005 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 30, 2005 | FAXX | FAX RECEIVED | — |
| Oct 12, 2004 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 20, 2004 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 30, 2004 | NPUB | NOTICE OF PUBLICATION | — |
| May 3, 2004 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 2, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 2, 2004 | PAPER RECEIVED | — | |
| Nov 17, 2003 | UNPR | UNRESPONSIVE/DUPLICATE PAPER RECEIVED | — |
| Nov 17, 2003 | PAPER RECEIVED | — | |
| Oct 15, 2003 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 6, 2003 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 6, 2003 | PAPER RECEIVED | — |